BIT's 18th Annual Congress of International Drug Discovery Science and Technology (IDDST-2020)

Rescheduled Notice

With cases of Covid-19 reaching new heights in the world, some states have to adapt rapidly with their rules and regulations. After seeking advice from the some agency and venue hotel in Amsterdam, also considering the traffic control and epidemic prevention, the committee must admit this July is not a good time for holding an event. So after serious consideration, the organizing committee decides to postpone this meeting to next July at Amsterdam, the Netherlands.Sincerely hope you can understand such a demanded action.

Apart from protecting our participants, rescheduling non-essential gathering and travel also aims to contain the spread of coronavirus disease and protect the health system which will otherwise be overwhelmed. Thank you very much for your understanding in the complex situation.

Event Committee

Welcome to IDDST

The Annual Congress of International Drug Discovery Science & Technology (IDDST), initiated from 2003, has been successfully organized in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA) and Kyoto (Japan) and has attracted more than 10000 participants from over 50 countries and regions in the previous 17 years. IDDST continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment.

Keynote Speakers

	Dr. Luc Van Hijfte, SVP Medicinal Chemistry, Symeres, the Netherlands		Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA
	Dr. Dan Some, Principal Scientist, Wyatt Technology Corporation, USA		Dr. Balazs Sarkadi, Professor, Semmelweis University, Hungary
	Dr. Uwe Schoenbeck, Senior Vice President & Chief Scientific Officer, Worldwide R & D, Pfizer, USA		Dr. Zsolt Bosnyak, VP, Global Medical Head Diabetes, Sanofi, France

Confirmed Renowned Speakers

Dr. Benno Rattel, Executive Director, Nonclinical Development, Amgen Research, Germany	Dr. Alexey RAK, Director of Bio Structure and Biophysics, Sanofi R&D, France	Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA
Dr. Marcus Bauser, Director, Medicinal Chemistry, Bayer AG, Germany	Dr. Finn Bauer, Global Head of Solid Formulations R&D, Merck KGaA, Germany	Dr. Florian Montel, Head of opnMe.com & CNS Project Leader, BoehringerIngelheim, Germany
Dr. Juhaeri JUHAERI, Vice President and Head, Epidemiology and Benefit-Risk Evaluation, Sanofi, USA	Dr. Mehrdad Ghashghaeinia, Professor, University Medical Center Schleswig-Holstein, Germany	Dr. Erminia Massarelli, Professor, City of Hope, USA
Dr. Stefan J. Platz, Senior Vice President, AstraZeneca, UK	Dr. John J. Miles, Professor, James Cook University, Australia	Dr. Daniel Bradley, Associate Director, Biogen, USA
Dr. Henk Leeuwis, Vice President, LioniX International, the Netherlands	Dr. Miriam Kidron, CSO,Oramed Pharmaceuticals, Isreal	Dr. Ralf Glatthar, Director, Novartis Pharma AG, Switzerland
Dr. Immanuel Lerner, Chief Executive Officer, Pepticom LTD, Isreal	Dr. Anthony W. Coleman, Research Director, Université de Lyon, France	Dr. Mircea Ciuca, Head, Medical Clinical Drug Safety, ViforPharma, Switzerland
Dr. Lucas P.J.J. Noldus, Founder & CEO, Noldus Information Technology bv, the Netherlands	Dr. Wilbur de Kruijf, VP, MedsprayPharma, the Netherlands	Dr. Hubert Pellikaan, NextstepPharma BV, the Netherlands
Dr. Faz Chowdhury, CEO, NemauraPharma Limited, UK	Dr. Joël Richard, Head of Technical and Pharmaceutical Operations, MedinCell, France	Dr. Khursheed Anwer, Executive Vice President & Chief Science Officer, Celsion Corporation, USA
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK	Dr. Michael Black, Head of Sales PHARMA, BENEO-Palatinit GmbH, Germany	Dr. Masha Poyurovsky, VicePresident, Kadmon Corporation, LLC, USA
Dr. Yaakov Naparstek, Professor of Medicine, Hadassah University Hospital, Israel	Dr. Michael Reilly, Executive Director, Alliance for Safe Biologic Medicine, USA	Dr. Luana Pesco Koplowitz, Chief Medical & Scientific Officer, DUCK FLATS Pharma, USA
Dr. Tom Mander, Chief Operating Officer, Domainex Ltd, UK	Dr. Lars Neumann, Director, Proteros biostructures GmbH, Germany	Dr. Raphael Serreau, Professor, Unité INSERM “Psycomadd“ Université Paris Sud, France
Dr. Sigrid Saaler-Reinhardt, Director, Midas Pharma GmbH, Germany	Dr. Monica Berrondo, CEO, Macromoltek - Molecular simulations simplified, USA	Dr. Andrea Cusack, CBO, Leon-nanodrugs GmbH, Germany
Dr. Hiroyuki Fukase, Director, Clinical Research Center, Clinical Research Hospital Tokyo, Japan	Dr. Didier Dubreuil, Professor, University of Nantes, France	Dr. Gilles Courtemanche, Associate Director, Antimicrobials Unit, BIOASTER, France
Dr. Eduard Stefan, Head, Institute of Biochemistry, University of Innsbruck, Austria	Dr. Albin (Jim) Nelson, Senior Principal/Owner, Schwegman Lundberg Woessner P.A., USA	Dr. Isaac Bright, Chief Executive Officer, RubrYc Therapeutics, Inc, USA
Dr. Anna Birukova, Professor of Medicine, University of Maryland, USA	Dr. Konstantin Birukov, Professor of Anesthesiology, University of Maryland, USA	Dr. Amrik Basran, CSO, Avacta Life Sciences, UK
Dr. Barry Morgan, CSO, Hitgen Ltd., USA	Dr. Roberta Bursi, Vice President R&D, InSilicoTrials Technologies, Italy	Dr. Sergey Suchkov, Director of The Center for Personalized Medicine, I.M. Sechenov First Moscow State Medical University, Russia
Dr. Michael Ovadia, Professor, Tel Aviv University, Israel	Dr. Lakshminarayan R. Ranganath, Professor, University of Liverpool, UK	Dr. Karin Schutze, CSO, CellTool GmbH, Germany
Dr. Andrew Hanneman, Associate Director, Mass Spectrometry, Charles River Laboratories, USA	Dr. Steven van Helden, Chief Technology Officer, Pivot Park Screening Centre B.V., Netherlands	Dr. Elaine M. Hull, Professor, Florida State University, USA

Exhibition and Poster

IDDST-2021 provides an ideal platform to showcase your novel technologies and products in the Netherlands. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Why Reserve a Booth at IDDST-2021
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall

Exhibition Date:
Set-up date: July 14, 2021
Show dates: July 15-17, 2021
Place: Amsterdam, the Netherlands

Exhibitors

Wyatt Technology

CellTool GmbH

Introduction to Amsterdam

Amsterdam is the capital city and most populous municipality of the Netherlands. Its status as the capital is mandated by the Constitution of the Netherlands. Amsterdam's main attractions include its historic canals, the Rijksmuseum, the Van Gogh Museum, the Stedelijk Museum, Hermitage Amsterdam, the Anne Frank House, the Scheepvaartmuseum, the Amsterdam Museum, the Heineken Experience, the Royal Palace of Amsterdam, Natura Artis Magistra, Hortus Botanicus Amsterdam, NEMO, the red-light district and many cannabis coffee shops. They draw more than 5 million international visitors annually. The city is also well known for its nightlife and festival activity; several of its nightclubs (Melkweg, Paradiso) are among the world's most famous. It is also one of the world's most multicultural cities, with at least 177 nationalities represented.

Conference Chairman